Evofem — Phexxi: House Rules

The first hormone-free contraceptive, launched as a permission slip to become queens of their own sex lives.

Real Chemistry — Senior Director, Strategy

Silver Cannes Lion · Gold CLIO · Shorty Award

The problem

A category running on resignation

Phexxi arrived FDA-approved and genuinely new — hormone-free, on demand, a mechanism of action the category had no shelf for. The obvious launch problem was education. The real one sat deeper: decades of limited and limiting options had taught women to stop asking for better.

The insight

Women are stuck in a trap of acceptance about their own reproductive health.

You can’t fix that with efficacy claims — acceptance isn’t a knowledge gap.

The move

Control as the product

House Rules skipped the mechanism lecture and sold what the mechanism actually buys: control. A disruptive, 360-degree launch built for sexually active women who set the rules of their own sex lives — birth control that shows up when she decides, on her terms, in her house. The science made the promise credible; the permission is what made it move.

Woman smiling and holding a box of a product called Phexxi, which appears to be a vaginal gel.
A collage of nine images displaying various products and advertisements related to birth control and reproductive health, including medication packages, promotional messages, and a couple discussing, with vibrant colors and modern designs.

Receipts

6 weeks after launch

+94%

New prescriptions

2B+

Earned impressions

#1

Most-followed pharma birth-control brand on Instagram

  • Dispensed units +82%

  • 87.8MM social views at 9.7% engagement

  • 2B+ earned reach including Ad Age, PR Week, and FiercePharma

  • Total prescriptions +81%

  • 82.6K high-value actions, up 171% on 2% less spend

  • 572K website sessions